Human gene therapy: Present and future Mark A. KayKathy Parker PonderSavio L. C. Woo 14th Annual San Antonio Breast Cancer Symposium — Plenary Lecture Pages: 83 - 93
Human papillomavirus in breast cancer Anna Di LonardoAldo VenutiMaria Luisa Marcante Report Pages: 95 - 100
Prognostic factors and natural history in lymph node-negative breast cancer patients Rodrigo ArriagadaLars Erik RutqvistAndrew Kramar Report Pages: 101 - 109
pS2 expression in primary breast carcinomas: Relationship to clinical and histological features and survival Ann D. ThorFrederick C. KoernerLaurent H. Schwartz Report Pages: 111 - 119
Prognostic factors in node-positive operable breast cancer patients receiving adjuvant chemotherapy E. RakowskyB. KleinH. Lurie Report Pages: 121 - 131
Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy for advanced breast cancer M. BontenbalA. S. Th. PlantingJ. G. M. Klijn Report Pages: 133 - 138
Comparison of pain, motion, and edema after modified radical mastectomy vs. local excision with axillary dissection and radiation Lynn GerberMarsha LampertErnest Demoss Report Pages: 139 - 145